Skip to main content
News Icon

COVIMMUNE being funded

A new consortium COVIMMUNE under the direction of Prof. Eicke Latz, speaker of the cluster of Excellence ImmunoSensation2 is being funded with around 2 Million Euros by the Federal Ministry of Education and Research (BMBF). The project "Understanding divergent host reactions to SARS-CoV-2 infections by precision immunology" (COVIMMUNE) brings together clinical researchers at the University Hospital Bonn who are involved in COVID-19 patient care with basic scientists with immunological expertise from the University of Bonn.

"We want to find out the connection between the mechanisms of the immune response to the SARS-CoV-2 infection and the clinical course of the disease," says Prof. Dr. Eicke Latz. Around two dozen personalities from disciplines such as virology, internal medicine, intensive care medicine, pulmonology, neurology, immunology, blood coagulation, bioinformatics and systems biology are involved. Together they want to contribute to a better understanding of the different course of the disease in SARS-CoV-2 infections. Prof. Natalio Garbi heads the sub-project of the consortium on adaptive immunity. He says: "We want to test whether the interaction of the innate and the acquired (adaptive) immune response is the key to eliminating the infection and developing long-term immunity without long-term health consequences."

The aim is to find out how the SARS-CoV-2 virus can trigger a misdirected immune response and what role this plays in severe COVID-19 disease courses. Furthermore, a clinical study will investigate which factors cause long-term damage to the lungs and the nervous system. Prof. Dr. Michael Heneka, whose sub-project in the consortium is looking at the secondary diseases of the lungs and the central nervous system caused by COVID-19, says: "It is not yet well understood how infection with the SARS-CoV-2 virus can trigger such secondary diseases. We want to examine these relationships in a clinical study in order to be able to offer better treatment options."


Contact

Prof. Dr. Eicke Latz

Institute of Innate Immunity, University of Bonn

Phone: 0228/287-51223

E-Mail: eicke.latz@uni-bonn.de

Related news

Showing how the genes relevant to diseases can be identified more easily - (clockwise from top left): Alexander Hoch, Katja Blumenstock, Marius Jentzsch, Caroline Fandrey und Prof. Jonathan Schmid-Burgk.

News categories: Publication

Colored nuclei reveal cellular key genes

The identification of genes involved in diseases is one of the major challenges of biomedical research. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have developed a method that makes their identification much easier and faster: they light up genome sequences in the cell nucleus. In contrast to complex screenings using established methods, the NIS-Seq method can be used to investigate the genetic determinants of almost any biological process in human cells. The study has now been published in Nature Biotechnology.
View entry
Prof. Dr. Pröbstel

News categories: Focus

Welcoming Anne-Katrin Pröbstel to ImmunoSensation

Our Cluster is delighted to welcome Prof. Dr. Anne-Katrin Pröbstel as a new member. Joining from the University of Basel, where she established herself as a leading expert in neuroimmunology and immune-microbiota interactions, Anne-Katrin Pröbstel brings her innovative research to our thriving immunological community in Bonn.
View entry
Prof. Dr. Kaan Boztug

News categories: Focus

Welcoming Kaan Boztug to ImmunoSensation

Our Cluster is delighted to announce that Prof. Dr. Kaan Boztug, a renowned immunologist and pediatrician from Vienna, has joined our growing scientific community.
View entry

Back to the news overview